Outlines broad discovery and development efforts targeting synthetic lethality and DNA-damage repair mechanisms, including PRMT5-MTA, SGR-3515 and SGR-2921 programs NEW YORK--(BUSINESS ...
SOUTH SAN FRANCISCO, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize ...
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...
Radiopharm Theranostics ADR (NASDAQ:RADX) is among the best Australian stocks to buy in 2026. Radiopharm Theranostics ADR ...
The most enjoyable part of a program director's job is seeing a group of enthusiastic students grow and mature over years into confident, well-trained researchers. Our task is made easier by the ...
Government and private insurers are gradually moving away from encounter-based reimbursement and rapidly developing new payment models that reward coordination of care and population health management ...
Immunology education does not stop after trainees complete their MD or PhD programs. With the continuous advancements made in our understanding of the immune system’s critical role in health and ...
Beginning in 1965, the UASOM Department of Psychiatry initiated a predoctoral clinical psychology internship. Prior to 1980, the Internship Training Consortium was the sole program dedicated to the ...
Choose from one of two sub-specialties in our program: our adult track, or our child and family track (you may choose to specialize in pediatric psychology within the latter). You can complete either ...
The clinical program adheres to the "scientist-practitioner" model. Research knowledge and experience are viewed as fundamental parts of student's education and critical to the role of a clinical ...
Division researchers conduct studies in the laboratory and at the bedside, where we run clinical trials investigating lifesaving therapies for patients. Our priority is translating our most promising ...